ECT2 and cancer: Increasing evidence suggests that the dysregulation of Ect2 correlates with many malignancies, and the suppression of Ect2 has been shown to impede tumor growth, indicating that ECT2 functions as an oncoprotein and plays a crucial role in cancer progression [48,51,[54], [55], [56], [57]].